CN104398913A - 一种治疗痛经的药物及其制备方法 - Google Patents
一种治疗痛经的药物及其制备方法 Download PDFInfo
- Publication number
- CN104398913A CN104398913A CN201410703954.9A CN201410703954A CN104398913A CN 104398913 A CN104398913 A CN 104398913A CN 201410703954 A CN201410703954 A CN 201410703954A CN 104398913 A CN104398913 A CN 104398913A
- Authority
- CN
- China
- Prior art keywords
- radix
- blood
- tablet
- medicine
- pill
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/533—Leonurus (motherwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
一种治疗痛经的药物及其制备方法,它是由当归、赤白芍、川断、黄柏、薏苡仁、泽兰、泽泻、牛膝、玄胡素、乌药、桂皮、益母草、党参、陈皮、黄芪按照一定比例配伍而成。本发明中药组合物能够通经脉,活血祛瘀,调经消水,补中益气,健脾益肺,养血生津,活血通经,润燥滑肠,除血痹,破坚积,益气止痛,增强机体免疫力,加速血循环,升高血压及发汗,扩张血管,血循环加速,缓和肌肉痉挛性疼痛,降低子宫内膜前列腺素含量成效显著,对治疗和缓解经期疼痛具有较好的疗效,且无毒副作用。
Description
技术领域
本发明涉及一种由中草药为原料药的中药组合物及其制备方法,具体的说是涉及一种治疗痛经的药物及其制备方法。
背景技术
痛经为最常见的妇科症状之一,指行经前后或月经期出现下腹部疼痛、坠胀,伴有腰酸、腰痛或其他不适,症状严重影响生活质量者。痛经分为原发性痛经和继发性两类,原发性痛经指生殖器官无器质性病变的痛经,占痛经90%以上;继发性痛经指由盆腔器质性疾病引起的痛经。原发性痛经的发生主要与月经时子宫内膜前列腺素含量增高有关。PGF2α含量升高时造成痛经的主要原因。PGF2α含量高可引起子宫平滑肌过强收缩,血管痉挛,造成子宫缺血、乏氧状态而出现痛经。西医治疗痛经,主要是让女性患者服用前列腺素合成酶抑制剂如布洛芬、酮洛芬、甲氯芬那酸、双氯芬酸,或者避孕药等,这些药物虽然对缓解痛经具有一定疗效,但只能短暂缓解痛经,但不能治本。毒副作用很大。
发明内容
本发明从临床医疗用药需求及中医组方辩证原则出发,提出一种主治原发性痛经的药物及其制备方法。它是由以下重量份数配比的原料药制备而成的药剂:当归6-14g、赤白芍6-14g、川断6-14g、黄柏6-14g、薏苡仁10-20g、泽兰6-14g、泽泻6-14g、牛膝6-14g、玄胡素6-14g、乌药3-10g、桂皮3-9g、益母草10-20g、党参10-20g、陈皮3-10g、黄芪15-25g。优选配比为:当归10g、赤白芍10g、川断10g、黄柏10g、薏苡仁15g、泽兰10g、泽泻10g、牛膝10g、玄胡素10g、乌药6g、桂皮5g、益母草15g、党参15g、陈皮6g、黄芪20g。所述药剂为汤剂、胶囊剂、片剂或丸剂。
所述胶囊剂、片剂、丸剂的制备方法步骤如下:
(1)取方中当归、赤白芍、川断、黄柏、薏苡仁、泽兰、泽泻、牛膝、玄胡素、乌药、桂皮、益母草、党参、陈皮、黄芪粉碎筛析;
(2)将步骤(1)中筛制的混合物加水煎煮2-3次,合并煎液、过滤,将虑液浓缩成70-80度时,胶囊、丸剂相对密度为1.0-1.6的稠膏,片剂相对密度为1.0-1.4的稠膏;
(3)制作胶囊、丸剂时:
将稠膏分离纯化、干燥,制成干颗粒;将干颗粒混合均匀,填充胶囊内即制成胶囊;将干颗粒喷加炼蜜、混合均匀,制成小丸即制成丸剂;
制作片剂时:
将2-4份淀粉与步骤(2)中的稠膏混合均匀,制成颗粒、干燥,制成干颗粒,将干颗粒压制成片剂,包糖衣,即制成片剂。
步骤(2)中所述的混合物,加水煎煮的优选次数为2次,第一次为60-80分钟,第二次为40-60分钟。
本发明药物原料药的药理如下:
当归:具有补血,活血,调经止痛,润燥滑肠功效。主血虚诸证,月经不调,经闭,痛经,症瘕结聚,崩漏,虚寒腹痛,痿痹,肌肤麻木,肠燥便难,赤痢后重,痈疽疮疡,跌扑损伤;
赤白芍:主治邪气腹痛,除血痹,破坚积,寒热,病疲,止痛,利小便,益气;
川断:补肝,强筋骨,定经络,止经中(筋骨)酸痛,安胎,适合用于治妇人白带,生新血,破瘀血,落死胎,止咳嗽咳血,治赤白便浊。
黄柏:具有清热,燥湿,泻火,解毒功效,治热痢,泄泻,消渴,黄疸,痿躄,梦遗,淋浊,痔疮,便血,赤白带下,骨蒸劳热,目赤肿痛,口舌生疮,疮疡肿毒;
薏苡仁:有健脾渗湿,除痹止泻功效,用于水肿、脚气、小便不利、湿痹拘挛、脾虚泄泻;
泽兰:[性味、归经] 辛,微温,入肝、膀胱经,具有活血祛瘀,利尿退肿功效,用于血滞经闭、症癜、产后瘀痛,水肿,跌打损伤
泽泻:性味:甘,寒;归经:入肾、膀胱经;功效:具有利水,渗湿,泄热功效,治小便不利,水肿胀满,呕吐,泻痢,痰饮,脚气,淋病,尿血;
牛膝:归经:入肝、肾经;具有活血通经功效,治产后腹痛,月经不调;
玄胡素:主治:尿血、皮下气痛或气块痛,久患心痛,身热足寒,腰体痛,偏、正头风,咳嗽;
乌药:现代医学证实,具有挥发油的兴奋作用:能兴奋大脑皮质,促进呼吸,兴奋心肌,加速血循环,升高血压及发汗,扩张血管,血循环加速,缓和肌肉痉挛性疼痛;具有抑菌作用:对金黄色葡萄球菌,甲型溶血性链球菌,伤寒杆菌,变形杆菌,绿脓杆菌,大肠杆菌均有抑制作用;对消化道的影响:对胃肠平滑肌有双重作用,能增加消化液的分泌;止血作用:能明显缩短血浆再钙化时间,促进血凝及良好的止血作用;
桂皮:益肝肾,通经脉,散风寒,除湿痹,暖腰膝,止呕吐。治筋骨疼痛,寒泄腹痛,霍乱呕吐,噎膈胸满,膀胱寒疝,腰膝现冷,风湿痹痛及跌损瘀滞等症;
益母草:主治活血,祛瘀,调经,消水。治月经不调,胎漏难产,胞衣不下,产后血晕,瘀血腹痛,崩中漏下,尿血,泻血,痈肿疮疡。[6] 祛瘀生新,又可用于跌打损伤,对女性湿热盆腔炎症有一定疗效;
党参:党参味甘,性平。有补中益气、止渴、健脾益肺,养血生津。用于脾肺气虚,食少倦怠,咳嗽虚喘,气血不足,面色萎黄,心悸气短,津伤口渴,内热消渴;
陈皮:主治理气健脾,燥湿化痰,用于胸脘胀满,食少吐泻,咳嗽痰多;
黄芪:性味:甘,微温。归经:归肺、脾、肝、肾经。有增强机体免疫功能、保肝、利尿、抗衰老、抗应激、降压和较广泛的抗菌作用;功能主治:用于表虚自汗、急慢性肾炎水肿、阳气虚弱、疮疡溃破、肺气虚证、气虚衰弱;肺气虚证:咳喘日久,气短神疲,痰雍于肺无力咯出。温肺定喘,健肺气之品。脾生痰,肺储痰,所以健太阴以祛痰,黄芪补气所以尤善治气虚。气虚衰弱:倦怠乏力,或中气下陷、脱肛、子宫脱垂。表虚自汗:多用于体虚表弱所致的自汗。
中医学认为痛经多有情志所伤、起居不慎或六淫为害等不同病因,并与素体及经期、经期前后特殊的生理环境有关。其病机主要是在此期间受到致病因素的影响,导致冲任瘀阻或寒凝经脉,使气血运行不畅,胞宫经血流通受碍,以致“不通则痛”:或冲任、胞宫失于濡养,不荣而痛.其病位在冲任、胞宫,变化在气血,表现为痛佂。其所以随月经周期发作,是与经期冲任气血变化有关。
因此,本发明以黄芪为君药,增强机体免疫力,保肝,利尿,抗菌,治阳气虚弱、肺气虚证。以益母草、党参、薏苡仁为臣药,活血祛瘀,调经消水,补中益气,止渴,健脾益肺,养血生津,健脾渗湿,除痹止泻。以当归、赤白芍、川断、黄柏、泽兰、泽泻、牛膝、玄胡素为佐药,补血活血,调经止痛,润燥滑肠,除血痹,破坚积,益气止痛,利小便, 治白带、赤白便浊,生新血,破瘀血, 清热解毒,燥湿泻火,消渴,治赤白带下、便血,利尿退肿,渗湿泄热,活血通经,治腹痛,月经不调,身热足寒,腰体痛。使以乌药、陈皮、桂皮,抑菌止血,加速血循环,升高血压及发汗,扩张血管,血循环加速,缓和肌肉痉挛性疼痛,理气健脾,燥湿化痰,通经脉,散风寒,除湿痹,暖腰膝。本发明所述的药物承中医之精髓、严谨组方,诸药君臣佐使合用,补破结合、相得益彰,符合中医用药规律和辨证施治的原则。
有益效果
本发明中药组合物能够通经脉,活血祛瘀,调经消水,补中益气,健脾益肺,养血生津,活血通经,润燥滑肠,除血痹,破坚积,益气止痛,增强机体免疫力,加速血循环,升高血压及发汗,扩张血管,血循环加速,缓和肌肉痉挛性疼痛,降低子宫内膜前列腺素含量成效显著,对治疗和缓解经期疼痛具有较好的疗效,且无毒副作用。
临床试验:
1、病例选择:
女性痛经固定周期在5天以上患者58例。
2、诊断标准
疼痛呈痉挛性,位于下腹部耻骨上,可放射至腰骶部和大腿内侧,伴有恶心、呕吐、腹泻、头晕、乏力等症状,严重时面色发白、出冷汗,妇科检查无其它异常发现。
3、治疗方案
实施例2所制胶囊,早中晚饭后半小时各一次,每次4粒,每粒0.3g,2天为一个疗程,2个疗程后观察统计。
4、疗效评价标准
显效:痛经周期缩短,且疼痛感减缓或消失;
有效:疼痛感减缓或消失,痛经周期无明显变化;
无效:痛经周期、疼痛感无明显变化;
总有效率=显效率+有效率。
5、数据统计
病例数 | 显效 | 有效 | 无效 | 显效率 | 总有效率 |
58例 | 53 | 5 | 0 | 91.38% | 100.00% |
6、结论
根据诊断标准和疗效评价标准,按照治疗方案治疗58例痛经固定周期在5天以上的女性患者,痛经周期明显缩短,且疼痛感减缓或消失的显效病例53例,显效率达到91.38%;有效5例,总有效率达到100%。
药效学试验:
本发明药物治疗缩宫素所致雌性大鼠痛经模拟试验:选择雌性大鼠30只,分为对照组、治疗组各15只,对照组和治疗组均注射己烯雌酚,每日1次,连续5天。治疗组注射己烯雌酚后的第二天灌胃本发明药物,每天一次,连续4天,记录两组雌性大鼠扭体的次数。发现治疗组雌性大鼠的扭体次数明显少于对照组,且扭体周期明显短于对照组。
子宫内膜前列腺素含量检测:第3天开始,用大鼠前列腺素F2α(PGF2α)ELISA检测试剂盒检查对照组合治疗组,利用双抗体夹心法,检测血浆中对应PGF2α标本的平均含量,治疗组PGF2α平均含量明显低于对照组。本发明药物对能够有效降低子宫内膜前列腺素含量(PGF2α指标含量),加强在体大鼠子宫平滑肌的抑制,明显减弱子宫收缩,降低疼痛,缩短周期。
急毒性试验:较大剂量和较长疗程服用对大鼠的生长无显著毒性,对大鼠的脑、心、肝、肾等切片形态学检查未见明显毒性损伤改变,试验显示,本药物毒性甚小。
具体实施方式
实施例1:一种治疗痛经的药物及其制备方法。它是由以下重量份数配比的原料药制备而成的药剂:当归6-14g、赤白芍6-14g、川断6-14g、黄柏6-14g、薏苡仁10-20g、泽兰6-14g、泽泻6-14g、牛膝6-14g、玄胡素6-14g、乌药3-10g、桂皮3-9g、益母草10-20g、党参10-20g、陈皮3-10g、黄芪15-25g。所述药剂为胶囊剂、片剂或丸剂。
按照下述重量份数配比称取原料药:
当归6-14g、赤白芍6-14g、川断6-14g、黄柏6-14g、薏苡仁10-20g、泽兰6-14g、泽泻6-14g、牛膝6-14g、玄胡素6-14g、乌药3-10g、桂皮3-9g、益母草10-20g、党参10-20g、陈皮3-10g、黄芪15-25g。
所述胶囊剂、片剂、丸剂的制备方法步骤如下:
(1)取方中当归、赤白芍、川断、黄柏、薏苡仁、泽兰、泽泻、牛膝、玄胡素、乌药、桂皮、益母草、党参、陈皮、黄芪粉碎筛析;
(2)将步骤(1)中筛制的混合物加水煎煮2-3次,合并煎液、过滤,将虑液浓缩成70-80度时,胶囊、丸剂相对密度为1.0-1.6的稠膏,片剂相对密度为1.0-1.4的稠膏;
(3)制作胶囊、丸剂时:
将稠膏分离纯化、干燥,制成干颗粒;将干颗粒混合均匀,填充胶囊内即制成胶囊;将干颗粒喷加炼蜜、混合均匀,制成小丸即制成丸剂;
制作片剂时:
将2-4份淀粉与步骤(2)中的稠膏混合均匀,制成颗粒、干燥,制成干颗粒,将干颗粒压制成片剂,包糖衣,即制成片剂。
步骤(2)中所述的混合物,加水煎煮的优选次数为2次,第一次为60-80分钟,第二次为40-60分钟。
实施例2:一种治疗痛经的药物及其制备方法。它是由以下重量份数配比的原料药制备而成的药剂:当归10g、赤白芍10g、川断10g、黄柏10g、薏苡仁15g、泽兰10g、泽泻10g、牛膝10g、玄胡素10g、乌药6g、桂皮5g、益母草15g、党参15g、陈皮6g、黄芪20g。所述药剂为胶囊剂、片剂或丸剂。
按照下述重量份数配比称取原料药:
当归10g、赤白芍10g、川断10g、黄柏10g、薏苡仁15g、泽兰10g、泽泻10g、牛膝10g、玄胡素10g、乌药6g、桂皮5g、益母草15g、党参15g、陈皮6g、黄芪20g。
所述胶囊剂、片剂、丸剂的制备方法步骤如下:
(1)取方中当归、赤白芍、川断、黄柏、薏苡仁、泽兰、泽泻、牛膝、玄胡素、乌药、桂皮、益母草、党参、陈皮、黄芪粉碎筛析;
(2)将步骤(1)中筛制的混合物加水煎煮2-3次,合并煎液、过滤,将虑液浓缩成70-80度时,胶囊、丸剂相对密度为1.0-1.6的稠膏,片剂相对密度为1.0-1.4的稠膏;
(3)制作胶囊、丸剂时:
将稠膏分离纯化、干燥,制成干颗粒;将干颗粒混合均匀,填充胶囊内即制成胶囊;将干颗粒喷加炼蜜、混合均匀,制成小丸即制成丸剂;
制作片剂时:
将2-4份淀粉与步骤(2)中的稠膏混合均匀,制成颗粒、干燥,制成干颗粒,将干颗粒压制成片剂,包糖衣,即制成片剂。
步骤(2)中所述的混合物,加水煎煮的优选次数为2次,第一次为60-80分钟,第二次为40-60分钟。
实施例3:本发明药物还可以为汤剂、口服液、颗粒剂等。
Claims (5)
1.一种治疗痛经的药物,其特征在于它是由以下重量份数配比的原料药制备而成的药剂:当归6-14g、赤白芍6-14g、川断6-14g、黄柏6-14g、薏苡仁10-20g、泽兰6-14g、泽泻6-14g、牛膝6-14g、玄胡素6-14g、乌药3-10g、桂皮3-9g、益母草10-20g、党参10-20g、陈皮3-10g、黄芪15-25g。
2.根据权利要求1所述的治疗痛经的药物,其特征在于它是由以下重量份数配比的原料药制备而成的药剂:当归10g、赤白芍10g、川断10g、黄柏10g、薏苡仁15g、泽兰10g、泽泻10g、牛膝10g、玄胡素10g、乌药6g、桂皮5g、益母草15g、党参15g、陈皮6g、黄芪20g。
3.根据权利要求1或2所述的治疗痛经的药物,其特征在于:所述药剂为汤剂、胶囊剂、片剂或丸剂。
4.根据权利要求3所述的治疗痛经的药物,其特征在于:所述胶囊剂、片剂、丸剂的制备方法步骤如下:
(1)取方中当归、赤白芍、川断、黄柏、薏苡仁、泽兰、泽泻、牛膝、玄胡素、乌药、桂皮、益母草、党参、陈皮、黄芪粉碎筛析;
(2)将步骤(1)中筛制的混合物加水煎煮2-3次,合并煎液、过滤,将虑液浓缩成70-80度时,胶囊、丸剂相对密度为1.0-1.6的稠膏,片剂相对密度为1.0-1.4的稠膏;
(3)制作胶囊、丸剂时:
将稠膏分离纯化、干燥,制成干颗粒;将干颗粒混合均匀,填充胶囊内即制成胶囊;将干颗粒喷加炼蜜、混合均匀,制成小丸即制成丸剂;
制作片剂时:
将2-4份淀粉与步骤(2)中的稠膏混合均匀,制成颗粒、干燥,制成干颗粒,将干颗粒压制成片剂,包糖衣,即制成片剂。
5.根据权利要求4所述的治疗痛经的药物的制备方法,其特征在于步骤(2)中所述的混合物,加水煎煮的次数为2次,第一次为60-80分钟,第二次为40-60分钟。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410703954.9A CN104398913A (zh) | 2014-11-30 | 2014-11-30 | 一种治疗痛经的药物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410703954.9A CN104398913A (zh) | 2014-11-30 | 2014-11-30 | 一种治疗痛经的药物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104398913A true CN104398913A (zh) | 2015-03-11 |
Family
ID=52636622
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410703954.9A Pending CN104398913A (zh) | 2014-11-30 | 2014-11-30 | 一种治疗痛经的药物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104398913A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104958738A (zh) * | 2015-07-29 | 2015-10-07 | 华菊 | 一种治疗痛经的药物及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100998722A (zh) * | 2006-12-28 | 2007-07-18 | 王玉秀 | 一种治疗月经后期痛经的内服中药 |
KR20110015172A (ko) * | 2009-08-07 | 2011-02-15 | 최장현 | 여성 생리불순 개선용 식물추출 조성물 |
-
2014
- 2014-11-30 CN CN201410703954.9A patent/CN104398913A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100998722A (zh) * | 2006-12-28 | 2007-07-18 | 王玉秀 | 一种治疗月经后期痛经的内服中药 |
KR20110015172A (ko) * | 2009-08-07 | 2011-02-15 | 최장현 | 여성 생리불순 개선용 식물추출 조성물 |
Non-Patent Citations (3)
Title |
---|
周德生等: "《中医名方全书》", 31 August 2012, 湖南科学技术出版社 * |
周黎民等: "泽兰汤治疗痛经120例", 《陕西中医》 * |
王婷婷等: "痛经中医辨证治疗", 《辽宁中医药大学学报》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104958738A (zh) * | 2015-07-29 | 2015-10-07 | 华菊 | 一种治疗痛经的药物及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101884770B (zh) | 治疗尿石症的中药制剂及其制备方法 | |
CN101700393B (zh) | 一种治疗乳腺癌的中药组合物 | |
CN104784673B (zh) | 一种用于小儿腹泻的中药脐贴 | |
CN102836409B (zh) | 用于治疗产后恶露不绝的中药及制备方法 | |
CN103301317B (zh) | 一种治疗脾虚气陷型痔疮的中药组合物 | |
CN101618201B (zh) | 一种治疗外阴粘膜白斑的药物 | |
CN103272189B (zh) | 一种治疗胆结石的药物 | |
CN103142722B (zh) | 一种治疗肝郁气滞型月经不调的中药组合物 | |
CN101700372B (zh) | 一种内服治疗慢性盆腔炎的药物 | |
CN103751721A (zh) | 一种治疗膀胱癌的中药组合物 | |
CN103656525A (zh) | 一种治疗痛经的中药组合物 | |
CN100388931C (zh) | 一种治疗盆腔炎的药物及其制备方法 | |
CN103405708B (zh) | 一种治疗慢性肠炎的药物及其制备方法 | |
CN104398913A (zh) | 一种治疗痛经的药物及其制备方法 | |
CN104288581A (zh) | 用于治疗先兆流产的中药 | |
CN104173610B (zh) | 一种治疗盆腔炎的中药制剂及制备方法 | |
CN105477264A (zh) | 一种治疗尿道综合症的药物制剂 | |
CN105169111A (zh) | 一种用于治疗慢性荨麻疹的中药组合物及其应用 | |
CN105327299A (zh) | 一种用于治疗原发性血小板减少紫癜的药物 | |
CN103127352B (zh) | 一种治疗血瘀型月经不调的中药组合物 | |
CN104288585A (zh) | 一种肾病中药 | |
CN104740040A (zh) | 一种治疗月经不调的中药汤剂 | |
CN104435362A (zh) | 一种治疗慢性盆腔炎的中药复方 | |
CN103989885A (zh) | 一种治疗慢性盆腔炎中药 | |
CN102716294A (zh) | 一种治疗妇科痛经病的中药散剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150311 |
|
RJ01 | Rejection of invention patent application after publication |